MyFibroScan for iOS

FibroScan is the first non-invasive medical device that streamlines your management of chronic liver disease, from screening to follow-up and prognosis.

Reference solution providing patented dual function capability VCTE (fibrosis) and CAP (steatosis), the FibroScan benefits from a worldwide clinical legitimacy and is recommended in the guidelines of leading organizations.

myFibroScan app is the best companion to enlarge the suite of diagnosis tools based on FibroScan results:

- interpret FibroScan examination results to assess fibrosis stage and steatosis grade, according to scientific publications, etiology and examination results VCTE and CAP with the Interpretation Guide tool

- assess the probability of active NASH with the new FAST score, combining FibroScan biomarkers of liver fibrosis (VCTE) and steatosis (CAP) with blood biomarker of liver inflammation (AST). Best-in-class diagnostic performance and broad applicability demonstrated on 1,300 patients from different clinical setting and geographical origin: consistent 0.85-0.90 average AUROCs performance